Impact of KIR/HLA-C interactions on the anti-HIV activity of NK cells
Impact of KIR/HLA-C interactions on the anti-HIV activity of NK cells
批准号:
410760607
负责人:
Dr. Christian Körner
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2018
资助国家:
德国
项目状态:
已结题
起止时间:
2017-12-31 至 2021-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Infection with the human immune deficiency virus (HIV) remains an eventually fatal disease in the absence of antiretroviral therapy. The difficulties to control the infection partially arise from numerous strategies HIV developed to evade host immune responses. Recently primary HIV isolates were identified that are able to downmodulate HLA-C through the accessory HIV protein Vpu leading to loss of recognition by T cells. Vpu-mediated modulation of HLA-C therefore represents a novel immune evasion mechanism and challenges previously established models. In this context, the applicant recently showed that NK cells expressing inhibitory KIR2DL receptors were able to sense HIV-mediated alterations of HLA-C surface expression on infected cells. These highly polymorphic receptors recognize HLA-C with differential affinities and dominate NK-cell responses. Given the extended polymorphism of HLA-C and KIR2DL receptors it is yet unknown to what extent KIR2DL/HLA-C allotype combinations determine the ability of NK cells to efficiently recognize HIV-infected cells, in particular in the setting of HIV-mediated downmodulation of HLA-C. Based on these findings, we hypothesize that KIR2DL/HLA-C interactions represent a major determinant for the magnitude of NK-cell-mediated immune pressure and potentially impact HIV disease progression. This proposal aims to investigate the impact of KIR2DL/HLA-C interactions on the anti-HIV activity of NK cells in the setting of HIV-mediated HLA-C downmodulation. Furthermore, we seek to determine the effects of KIR2DL/HLA-C interactions on Vpu-associated viral evolution in vivo and in vitro. Using an autologous in vitro infection system the anti-HIV activity of KIR2DL+ NK cells will be assessed. Additionally, NK-cell-driven viral evolution within Vpu will be identified in primary isolates and in vitro through next generation sequencing. Altogether, the results obtained from this proposal will provide critical information on the mechanisms underlying NK-cell-mediated recognition of HIV-infected cells and the ability of HIV to evade NK-cell-mediated immune pressure by modulating HLA-C expression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
登录
查看更多内容
KIR-HLA受配体相合度对免疫性血小板输注无效的影响及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
rs9378141影响GATA1转录激活HLA-G调节KIR2DL4通路诱导CSU患者肥大细胞脱颗粒机制
-
批准号:82373487
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:肖汀
-
依托单位:
自杀基因调控基于KIR-HLA错配基因型aNK细胞对HCC作用的实验研究
-
批准号:82360589
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:吴涛
-
依托单位:
NK高表达受体KIR3DL2胞啃肿瘤细胞HLA-A导致头颈鳞癌PD-1单抗耐药的机制研究
-
批准号:82304545
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李然
-
依托单位:
HLA-B*13:01/KIR3DL1相关通路介导伴药物性肝损的DRESS发病机制的研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:55万元
-
批准年份:2021
-
负责人:骆肖群
-
依托单位:
KIR2DL3新变异体与配基HLA-C 结合特性的研究
-
批准号:81401732
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2014
-
负责人:和艳敏
-
依托单位:
KIR及其配体HLA-I多态性与HCV感染自然转归和Peg-IFN/RBV疗效的相关性研究
-
批准号:81402733
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2014
-
负责人:戎霞
-
依托单位:
KIR基因家族测序分型技术及HLA-C—KIR精细组合型对肝移植急性排斥影响的系列研究
-
批准号:81373158
-
项目类别:面上项目
-
资助金额:70.0万元
-
批准年份:2013
-
负责人:邓志辉
-
依托单位:
KIR/HLA复合基因在隐匿性乙肝免疫逃逸中的机制研究
-
批准号:81202313
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2012
-
负责人:沈春梅
-
依托单位:
HLA-C/KIR基因多态性与中国北方人群HIV-1易感性及AIDS进展的关联研究
-
批准号:81102278
-
项目类别:青年科学基金项目
-
资助金额:14.0万元
-
批准年份:2011
-
负责人:徐丽丹
-
依托单位: